Cytokinetics Announces Pricing of Public Offering of Common

Cytokinetics Announces Pricing of Public Offering of Common Stock
July 20, 2021 23:15 ET
| Source:
Cytokinetics, Incorporated
Cytokinetics, Incorporated
South San Francisco, California, UNITED STATES
SOUTH SAN FRANCISCO, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a price to the public of $27.50 per share, before underwriting discounts and commissions. The gross proceeds to Cytokinetics from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Cytokinetics, are expected to be $275 million. The offering is expected to close on July 23, 2021, subject to customary closing conditions. Additionally, Cytokinetics has granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of its common stock at the public offering price, less underwriting discounts and commissions. All of the shares of common stock in the offering will be sold by Cytokinetics.

Related Keywords

New York ,United States ,Edgewood ,Diane Weiser ,Morgan Stanley ,Broadridge Financial Solutions ,Jp Morgan Securities ,Corporate Communications Investor Relations ,Needham Company ,Exchange Commission ,Cytokinetics Incorporated Nasdaq ,Prospectus Department ,Hc Wainwright Co ,Morgan Stanley Co ,Island Avenue ,Cytokinetic Quarterly Report ,Vice President ,Corporate Communications ,புதியது யார்க் ,ஒன்றுபட்டது மாநிலங்களில் ,எட்ஜ்வுட் ,டயான் வீசர் ,மோர்கன் ஸ்டான்லி ,பிராட்ரிட்ஜ் நிதி தீர்வுகள் ,ஜ்ப் மோர்கன் பத்திரங்கள் ,பெருநிறுவன தகவல்தொடர்புகள் முதலீட்டாளர் உறவுகள் ,நீட்ஹாம் நிறுவனம் ,பரிமாற்றம் தரகு ,ப்ரோஸ்பெக்டஸ் துறை ,ஹ்ஸீ வேந்‌ரைட் இணை ,மோர்கன் ஸ்டான்லி இணை ,தீவு அவென்யூ ,துணை ப்ரெஸிடெஂட் ,பெருநிறுவன தகவல்தொடர்புகள் ,